Hep C - Novelos Therapeutics Closes $15 Million Private Placement

Novelos Therapeutics Closes $15 Million Private Placement
Genetic Engineering News - Novelos Therapeutics, Inc. (OTCBB: NVLT), a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, announced that today, it closed its previously announced private placement resulting in $15.06 million in

Valeant says Viramidine did not meet efficacy goal
Reuters - NEW YORK, March 21 (Reuters) - Valeant Pharmaceuticals International (VRX.N: Quote , Profile , Research ) said on Tuesday a late-stage trial of its chronic hepatitis C treatment Viramidine did not meet the efficacy goal on an overall basis. It said

Highlights of rising and falling U.S. stocks
Investors Business Daily - Bally Total Fitness Holding ( BFT ) shares ended Tuesday's session with a 14.7% gain following a report that Virgin Group, run by billionaire Richard Branson, is mulling a takeover of the company. See full story. Shares of Corus Group Plc ( CGA

Highlights of rising and falling U.S. stocks
Investors Business Daily - Cendant Corp. ( CD ) shares gained in early Tuesday trade after the company said it sees first-quarter earnings coming in at the upper end of its forecast of 11-16 cents a share. A survey of analysts by Thomson First Call is predicting earnings of 14